Patent US6585764B2 successfully refreshed from Google Patents.
US6585764B2
Expired / Lapsed
US
⏱️ 0.0 years remaining
Stent with therapeutically active dosage of rapamycin coated thereon
Assignee: Cordis US Corp
•
Filing: 2001-06-04
•
Granted: 2003-07-01
•
Expires: 2021-06-04
Abstract
Abstract Delivery of rapamycin locally, particularly from intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.
Inventors
- 👤 Carol Wright
- 👤 Gerard H. Llanos
- 👤 Ronald Rakos
- 👤 Kristen King
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 21:25
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/86; A61F2/90; A61F2/91; A61F2/915; A61L; A61L31/00; A61L31/08; A61L31/10; A61L31/14; A61L31/16; A61P; A61P9/00; A61F2002/91533; A61F2002/91541; A61F2002/9155; A61F2002/91558; A61F2250/00; A61F2250/0058; A61F2250/0067; A61F2250/0068; A61L2300/00; A61L2300/40; A61L2300/416; A61L2300/60; A61L2300/606
Claims Analysis
Total Claims: 29
Claim 1
Independent Claim
25 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin; and said coating applied to said stent.
Claim 2
Dependent Claim
25 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin; and said coating applied to said stent.
Claim 3
Dependent Claim
10 words
The stent of claim 1 wherein the stent is dip-coated.
Claim 4
Dependent Claim
13 words
The stent of claim 1 wherein the stent is sprayed with said coating.
Claim 5
Dependent Claim
29 words
A stent having a coating containing rapamycin or its analogs, wherein said rapamycin or said analogs are contained in the coating at a weight percentage of 0.0001% to 30%.
Claim 6
Dependent Claim
29 words
A stent having a coating containing rapamycin or its analogs, wherein said rapamycin or said analogs are contained in the coating at a weight percentage of 0.0001% to 30%.
Claim 7
Dependent Claim
16 words
The stent of claim 4 wherein a polymer is mixed to the rapamycin or its analogs.
Claim 8
Dependent Claim
16 words
The stent of claim 4 wherein a polymer is bound to the rapamycin or its analogs.
Claim 9
Dependent Claim
22 words
The stent of claim 4 wherein the rapamycin or its analogs is entrapped on the surface of the stent by a polymer.
Claim 10
Dependent Claim
57 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; wherein the polymer is biocompatible and degradable; and wherein the polymer is chosen from: lactone-based polyesters, lactone-based copolyesters; polyanhydrides; polyaminoacids; polysaccharides; polyphosphazenes; poly(ether-ester) copolymers, and blends of such polymers.
Claim 11
Dependent Claim
57 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; wherein the polymer is biocompatible and degradable; and wherein the polymer is chosen from: lactone-based polyesters, lactone-based copolyesters; polyanhydrides; polyaminoacids; polysaccharides; polyphosphazenes; poly(ether-ester) copolymers, and blends of such polymers.
Claim 12
Dependent Claim
50 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; and wherein the polymer is chosen from: lactone-based polyesters, lactone-based copolyesters; polyanhydrides; polyaminoacids; polysaccharides; polyphosphazenes; poly(ether-ester) copolymers, and blends of such polymers.
Claim 13
Dependent Claim
50 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; and wherein the polymer is chosen from: lactone-based polyesters, lactone-based copolyesters; polyanhydrides; polyaminoacids; polysaccharides; polyphosphazenes; poly(ether-ester) copolymers, and blends of such polymers.
Claim 14
Dependent Claim
49 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; wherein the polymer is nonabsorbable; and wherein the polymer is chosen from: polydimethylsiolxane; poly(ethylene)vinylacetate; poly(hydroxy)ethylmethylmethacrylate, polyvinyl pyrrolidone; polytetrafluoroethylene; and cellulose esters.
Claim 15
Dependent Claim
49 words
A stent having a coating containing rapamycin, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; wherein the polymer is nonabsorbable; and wherein the polymer is chosen from: polydimethylsiolxane; poly(ethylene)vinylacetate; poly(hydroxy)ethylmethylmethacrylate, polyvinyl pyrrolidone; polytetrafluoroethylene; and cellulose esters.
Claim 16
Dependent Claim
47 words
A stent having a coating containing rapamycin or its analogs, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; and wherein the polymer is chosen from: polydimethylsiolxane; poly(ethylene)vinylacetate; poly(hydroxy)ethylmethylmethacrylate, polyvinyl pyrrolidone; polytetrafluoroethylene; and cellulose esters.
Claim 17
Dependent Claim
47 words
A stent having a coating containing rapamycin or its analogs, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; and wherein the polymer is chosen from: polydimethylsiolxane; poly(ethylene)vinylacetate; poly(hydroxy)ethylmethylmethacrylate, polyvinyl pyrrolidone; polytetrafluoroethylene; and cellulose esters.
Claim 18
Dependent Claim
98 words
A stent having a coating containing rapamycin or its analogs, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; and further comprising: a generally thin walled cylinder, said cylinder containing a plurality of generally solid struts, said applied to said strut, and a channel formed in at least one of said struts, said channel having a closed perimeter on all sides and an open top, and said channel smaller in all dimensions than said strut, said channel containing a reservoir of said rapamycin coating applied therein.
Claim 19
Dependent Claim
98 words
A stent having a coating containing rapamycin or its analogs, said coating formed from a polymer mixed carrier containing the rapamycin or its analogs; and said coating applied to said stent; and further comprising: a generally thin walled cylinder, said cylinder containing a plurality of generally solid struts, said applied to said strut, and a channel formed in at least one of said struts, said channel having a closed perimeter on all sides and an open top, and said channel smaller in all dimensions than said strut, said channel containing a reservoir of said rapamycin coating applied therein.
Claim 20
Dependent Claim
35 words
A stent having a coating containing rapamycin or its analogs, wherein said rapamycin or said analogs are contained in the coating at a weight percentage of 0.0001% to 30%, wherein the coating is a polymer.
Claim 21
Dependent Claim
35 words
A stent having a coating containing rapamycin or its analogs, wherein said rapamycin or said analogs are contained in the coating at a weight percentage of 0.0001% to 30%, wherein the coating is a polymer.
Claim 22
Dependent Claim
16 words
The stent of claim 13 wherein said polymer is mixed to the rapamycin or its analogs.
Claim 23
Dependent Claim
16 words
The stent of claim 4 wherein said polymer is bound to the rapamycin or its analogs.
Claim 24
Dependent Claim
22 words
The stent of claim 13 wherein the rapamycin or its analogs is entrapped on the surface of the stent by said polymer.
Claim 25
Dependent Claim
26 words
A stent containing a polymer and rapamycin or its analogs wherein said rapamycin or its analogs are contained in a therapeutically beneficial amount to combat restenosis.
Claim 26
Dependent Claim
26 words
A stent containing a polymer and rapamycin or its analogs wherein said rapamycin or its analogs are contained in a therapeutically beneficial amount to combat restenosis.
Claim 27
Dependent Claim
16 words
The stent of claim 17 wherein said polymer is mixed to the rapamycin or its analogs.
Claim 28
Dependent Claim
16 words
The stent of claim 17 wherein said polymer is bound to the rapamycin or its analogs.
Claim 29
Dependent Claim
22 words
The stent of claim 17 wherein the rapamycin or its analogs is entrapped on the surface of the stent by said polymer.
References Cited (Backward Citations)
US5234456A
Cited
US5871535A
Cited
US5851217A
Cited
US5725567A
Cited
US5851231A
Cited
US5545208A
Cited
US5893840A
Cited
US5769883A
Cited
US5551954A
Cited
US5464450A
Cited
US5500013A
Cited
US5563146A
Cited
US5646160A
Cited
US5516781A
Cited
US5591224A
Cited
US5599352A
Cited
US5651174A
Cited
US5554182A
Cited
US5849034A
Cited
US5282823A
Cited
US5443496A
Cited
US5571166A
Cited
US5628785A
Cited
US5799384A
Cited
US5800507A
Cited
US5510077A
Cited
US5591227A
Cited
US5697967A
Cited
US5288711A
Cited
US5383928A
Cited
US5283257A
Cited
US5578075B1
Cited
US5578075A
Cited
US5449382A
Cited
US5342348A
Cited
US5562922A
Cited
US5607463A
Cited
US5824048A
Cited
US5679400A
Cited
US5464650A
Cited
US5837008A
Cited
US5776184A
Cited
US5624411A
Cited
US5932243A
Cited
US5735897A
Cited
US5693085A
Cited
US5629077A
Cited
US5788979A
Cited
US5882335A
Cited
US5649977A
Cited
US5632840A
Cited
EP0761251A1
Cited
US5733327A
Cited
US5707385A
Cited
EP0712615A1
Cited
US5665591A
Cited
EP0716836A1
Cited
US5637113A
Cited
US5700286A
Cited
US5605696A
Cited
US5755772A
Cited
US5837313A
Cited
WO1996032907A1
Cited
US5674242A
Cited
US5603722A
Cited
US5820917A
Cited
US5824049A
Cited
US5609629A
Cited
US5865814A
Cited
US5679659A
Cited
US5782908A
Cited
US5607475A
Cited
US5672638A
Cited
WO1997033534A1
Cited
US5968091A
Cited
US5820918A
Cited
US5728150A
Cited
US5728420A
Cited
US5833651A
Cited
WO1998023228A1
Cited
EP0850651A2
Cited
WO1998034669A1
Cited
US5843172A
Cited
US6273913B1
Cited
WO1998047447A1
Cited
US5879697A
Cited
WO1998056312A1
Cited
US6015432A
Cited
EP0938878A2
Cited
US6153252A
Cited
US6369039B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2006-06-30 | 2006-12-30 | 2007-07-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2010-06-30 | 2010-12-30 | 2011-07-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2014-06-30 | 2014-12-30 | 2015-07-01 | $7700.00 | Window Closed / Lapsed |